Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03NTQ
|
|||
| Former ID |
DNC013999
|
|||
| Drug Name |
7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one
|
|||
| Synonyms |
CHEMBL455556; 7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one; SCHEMBL2161875; BDBM50262479
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H20N2O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CC=C2
|
|||
| InChI |
1S/C17H20N2O/c20-17(16-12-8-14-18-19-16)13-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-12,14H,1-2,4,7,9,13H2
|
|||
| InChIKey |
DXGZKZUTNHLJNE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.